Chongqing Chinabase Showcases Core Products Across Multiple Sectors at CPHI Korea 2026

From August 25 to 27, 2026, CPHI Korea 2026, one of the most influential pharmaceutical industry events across the Asia‑Pacific region, was held at COEX Convention & Exhibition Center in Seoul, South Korea.

Chongqing Chinabase participated in the exhibition with its flagship products including Ilaprazole, Orforglipron, Tranexamic Acid, 1,2‑Octanediol and Alpha‑GPC. The exhibited products cover three major application sectors: pharmaceuticals, cosmetics and health supplements. Thanks to consistent product quality and versatile application adaptability, the company drew extensive attention from global buyers on‑site.

At the exhibition venue, the booth of Chongqing Chinabase drew industry clients from South Korea, Japan, India and many other countries and regions, who stopped by for exchanges. Our team held one‑on‑one in‑depth discussions with visiting buyers concerning product compliance standards, technical specifications, supply‑chain delivery capacity and customized solutions. Among the displayed offerings, the oral GLP‑1 raw material Orforglipron and the brain‑health‑focused ingredient Alpha‑GPC stood out as the two most‑noticed products at the show. Numerous clients visited the booth specifically to inquire about product details and long‑term cooperation models. Several preliminary cooperation intentions were reached with industry partners during the exhibition, and follow‑up work will be carried out to deliver long‑term and stable business collaborations.